May 22, 2012
The misuse of prescription opioids has been an issue of growing concern in Ontario, as well as in the rest of Canada. OxyContin has in particular been popular due to its high potency and long-lasting effects.
On March 1, 2012, Purdue Pharma stopped distributing this brand name oxycodone formulation and replaced it with a tamper-resistant formulation called OxyNEO.
Ontario also decided to restrict access to OxyNEO by funding it through the Exceptional Access Program and the Facilitated Access to Palliative Care Drugs mechanism. This decision balances appropriate use, patient care and the growing problem of opioid addiction in Ontario, and was based on advice from Ontario's Committee to Evaluate Drugs and extensive discussions with pain specialists, addiction experts and other health care providers.
In light of these changes, Ontario is taking action to help people who were using OxyContin find harm reduction programs and addiction treatment should they wish to make changes. Below are links to resources meant to assist people using opioids, their families and health care professionals.
Important Contact Information for people using opioids and their families:
For more information, see:
Call ServiceOntario, Infoline at 1-866-532-3161
In Toronto, 416-314-5518
In Toronto, TTY 416-327-4282
Hours of operation : 8:30am - 5:00pm